Cefpodoximeproxetil impurity B is a constituent found in Cefpodoximeproxetil, which is a third-generation cephalosporin. This compound, known as CefpodoximeProxetil, is a highly effective oral antibiotic with a broad spectrum of activity.
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoximeproxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.